<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35632784</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>13</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Clearance of Persistent SARS-CoV-2 RNA Detection in a NF&#x3ba;B-Deficient Patient in Association with the Ingestion of Human Breast Milk: A Case Report.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1042</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14051042</ELocationID><Abstract><AbstractText>Currently, there are no evidence-based treatment options for long COVID-19, and it is known that SARS-CoV-2 can persist in part of the infected patients, especially those with immunosuppression. Since there is a robust secretion of SARS-CoV-2-specific highly-neutralizing IgA antibodies in breast milk, and because this immunoglobulin plays an essential role against respiratory virus infection in mucosa cells, being, in addition, more potent in neutralizing SARS-CoV-2 than IgG, here we report the clinical course of an NF&#x3ba;B-deficient patient chronically infected with the SARS-CoV-2 Gamma variant, who, after a non-full effective treatment with plasma infusion, received breast milk from a vaccinated mother by oral route as treatment for COVID-19. After such treatment, the symptoms improved, and the patient was systematically tested negative for SARS-CoV-2. Thus, we hypothesize that IgA and IgG secreted antibodies present in breast milk could be useful to treat persistent SARS-CoV-2 infection in immunodeficient patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Janine S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0001-6502-1206</Identifier><AffiliationInfo><Affiliation>Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas 13083-887, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amorim</LastName><ForeName>Mariene R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-8516-0155</Identifier><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>William M</ForeName><Initials>WM</Initials><AffiliationInfo><Affiliation>World Reference Center for Emerging Viruses, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marega</LastName><ForeName>Lia F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas 13083-887, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mofatto</LastName><ForeName>Luciana S</ForeName><Initials>LS</Initials><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toledo-Teixeira</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-4055-058X</Identifier><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forato</LastName><ForeName>Julia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stabeli</LastName><ForeName>Rodrigo G</ForeName><Initials>RG</Initials><Identifier Source="ORCID">0000-0002-0476-920X</Identifier><AffiliationInfo><Affiliation>Oswaldo Cruz Foundation (Fiocruz-SP), Ribeir&#xe3;o Preto 14049-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Public Health Emergency, Preparedness and Disaster, PAHO/WHO, Brasilia 70312-970, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Costa</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Campinas, Campinas 13083-887, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spilki</LastName><ForeName>Fernando R</ForeName><Initials>FR</Initials><Identifier Source="ORCID">0000-0001-5804-7045</Identifier><AffiliationInfo><Affiliation>One Health Laboratory, Feevale University, Novo Hamburgo 93510-235, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Ester C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Tropical Medicine Institute, Medical School, University of S&#xe3;o Paulo, S&#xe3;o Paulo 5403-907, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious and Parasitic Disease, Medical School, University of S&#xe3;o Paulo, S&#xe3;o Paulo 05403-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faria</LastName><ForeName>Nuno R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Department of Infectious and Parasitic Disease, Medical School, University of S&#xe3;o Paulo, S&#xe3;o Paulo 05403-000, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Zoology, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, London SW7 2AZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benites</LastName><ForeName>Bruno D</ForeName><Initials>BD</Initials><Identifier Source="ORCID">0000-0003-3985-5690</Identifier><AffiliationInfo><Affiliation>Hematology and Transfusion Medicine Center, University of Campinas, Campinas 13083-878, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Addas-Carvalho</LastName><ForeName>Marcelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-0178-6191</Identifier><AffiliationInfo><Affiliation>Hematology and Transfusion Medicine Center, University of Campinas, Campinas 13083-878, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stucchi</LastName><ForeName>Raquel S B</ForeName><Initials>RSB</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, University of Campinas, Campinas 13083-887, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Dewton M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Laboratory of Investigation in Dermatology and Immunodeficiencies, Department of Dermatology, Medical School, University of S&#xe3;o Paulo, S&#xe3;o Paulo 05403-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weaver</LastName><ForeName>Scott C</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0001-8016-8556</Identifier><AffiliationInfo><Affiliation>World Reference Center for Emerging Viruses, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granja</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3602-8550</Identifier><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biodiversity Research Centre, Federal University of Roraima, Boa Vista 72000-000, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proenca-Modena</LastName><ForeName>Jos&#xe9; Luiz</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-4996-3153</Identifier><AffiliationInfo><Affiliation>Laboratory of Emerging Viruses, Department of Genetics, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Experimental Medicine Research Cluster (EMRC), University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hub of Global Health (HGH), University of Campinas, Campinas 13083-862, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vilela</LastName><ForeName>Maria Marluce Dos S</ForeName><Initials>MMDS</Initials><AffiliationInfo><Affiliation>Laboratory of Pediatric Immunology, Center for Investigation in Pediatrics, Faculty of Medical Sciences, University of Campinas, Campinas 13083-887, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MR/R015600/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/S019510/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R24 AI120942</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MR/S0195/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>05</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007070">Immunoglobulin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004435" MajorTopicYN="N">Eating</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007070" MajorTopicYN="N">Immunoglobulin A</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008895" MajorTopicYN="N">Milk, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">IgA</Keyword><Keyword MajorTopicYN="N">NF&#x3ba;B-deficiency</Keyword><Keyword MajorTopicYN="N">breast milk</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">persistent SARS-CoV-2 infection</Keyword></KeywordList><CoiStatement>The authors declare that they have no relevant conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>5</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>5</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35632784</ArticleId><ArticleId IdType="pmc">PMC9143223</ArticleId><ArticleId IdType="doi">10.3390/v14051042</ArticleId><ArticleId IdType="pii">v14051042</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown K., Yahyouche A., Haroon S., Camaradou J., Turner G. Long COVID and self-management. Lancet. 2022;399:355. doi: 10.1016/S0140-6736(21)02798-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02798-7</ArticleId><ArticleId IdType="pmc">PMC8776283</ArticleId><ArticleId IdType="pubmed">35065779</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B., Fan J., Huang J., Guo E., Fu Y., Liu S., Xiao R., Liu C., Lu F., Qin T., et al. Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection. Nat. Commun. 2021;12:3501. doi: 10.1038/s41467-021-23621-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23621-y</ArticleId><ArticleId IdType="pmc">PMC8190301</ArticleId><ArticleId IdType="pubmed">34108465</ArticleId></ArticleIdList></Reference><Reference><Citation>See R.H., Zakhartchouk A.N., Petrick M., Lawrence D.J., Mok C.P.Y., Hogan R.J., Rowe T., Zitzow L.A., Karunakaran K.P., Hitt M.M., et al. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidatesin mice challenged with SARS coronavirus. J. Gen. Virol. 2006;87:641&#x2013;650. doi: 10.1099/vir.0.81579-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81579-0</ArticleId><ArticleId IdType="pubmed">16476986</ArticleId></ArticleIdList></Reference><Reference><Citation>Asahi-Ozaki Y., Yoshikawa T., Iwakura Y., Suzuki Y., Tamura S., Kurata T., Sata T. Secretory IgA Antibodies Provide Cross-ProtectionAgainst Infection with Different Strainsof Influenza B Virus. J. Med. Virol. 2004;74:328&#x2013;335. doi: 10.1002/jmv.20173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.20173</ArticleId><ArticleId IdType="pubmed">15332283</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L., Kallolimath S., Palt R., Stiasny K., Mayrhofer P., Maresch D., Eidenberger L., Steinkellner H. Increased in vitro neutralizing activity of SARS-CoV-2 IgA1 dimers compared to monomers and IgG. Proc. Nat. Acad. Sci. USA. 2021;118:e2107148118. doi: 10.1073/pnas.2107148118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2107148118</ArticleId><ArticleId IdType="pmc">PMC8612245</ArticleId><ArticleId IdType="pubmed">34702738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterlin D., Mathian A., Miyara M., Mohr A., Anna F., Cla&#xeb;r L., Quentric P., Fadlallah J., Devilliers H., Ghillani P., et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci. Transl. Med. 2021;13:eabd2223. doi: 10.1126/scitranslmed.abd2223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abd2223</ArticleId><ArticleId IdType="pmc">PMC7857408</ArticleId><ArticleId IdType="pubmed">33288662</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace R., Williams J.E., J&#xe4;rvinen K.M., Belfort M.B., Pace C.D.W., Lackey K.A., Gogel A.C., Nguyen-Contant P., Kanagaiah P., Fitzgerald T., et al. Characterization of SARS-CoV-2 RNA, Antibodies, and Neutralizing Capacity in Milk Produced by Women with COVID-19. mBio. 2021;12:e03192-20. doi: 10.1128/mBio.03192-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.03192-20</ArticleId><ArticleId IdType="pmc">PMC7885115</ArticleId><ArticleId IdType="pubmed">33563823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenzini T., Fliegauf M., Klammer N., Frede N., Proietti M., Bulashevska A., Camacho-Ordonez N., Varjosalo M., Kinnunen M., de Vries E., et al. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations. J. Allergy Clin. Immunol. 2020;146:901&#x2013;911. doi: 10.1016/j.jaci.2019.11.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.11.051</ArticleId><ArticleId IdType="pmc">PMC8246418</ArticleId><ArticleId IdType="pubmed">32278790</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza W.M., Amorim M.R., Sesti-Costa R., Coimbra L.D., Brunetti N.S., Toledo-Teixeira D.A., de Souza G.F., Muraro S.P., Parise P.L., Barbosa P.P., et al. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: An immunological study. Lancet Microbe. 2021;2:E527&#x2013;E535.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8266272</ArticleId><ArticleId IdType="pubmed">34258603</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S., Gurry C., Freitas L., Schultz M.B., Bach G., Diallo A., Akite N., Ho J., Lee R.T.C., Yeo W., et al. GISAID&#x2019;s Role in Pandemic Response. China CDC Wkly. 2021;3:1049&#x2013;1051. doi: 10.46234/ccdcw2021.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong D.S.Y., Claas E.C.J., Breijer S., Vaessen N. Comparison of the GeneFinder TM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITeInGenius to the national reference method: An added value of N gene target detection? J. Clin. Virol. 2020;132:104632. doi: 10.1016/j.jcv.2020.104632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104632</ArticleId><ArticleId IdType="pmc">PMC7475767</ArticleId><ArticleId IdType="pubmed">32932152</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman V.M., Landt O., Kaiser M., Molenkamp R., Meijer A., Chu D.K., Bleicker T., Br&#xfc;nink S., Schneider J., Schmidt M.L., et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria N.R., Mellan T.A., Whittaker C., Claro I.M., Candido D.D.S., Mishra S., Crispim M.A.E., Sales F.C., Hawryluk C., McCrone J.T., et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science. 2021;372:815&#x2013;821. doi: 10.1126/science.abh2644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh2644</ArticleId><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Candido D.S., Claro I.M., de Jesus J.G., Souza W.M., Moreira F.R.R., Dellicour S., Mellan T.A., du Plessis L., Pereira R.H.M., Sales F.C.S., et al. Evolution and epidemic spread of SARS-CoV-2 in Brazil. Science. 2020;369:1255&#x2013;1260. doi: 10.1126/science.abd2161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd2161</ArticleId><ArticleId IdType="pmc">PMC7402630</ArticleId><ArticleId IdType="pubmed">32703910</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahlin K., M&#xe4;kinen V. Accurate spliced alignment of long RNA sequencing reads. Bioinformatics. 2021;37:4643&#x2013;4651. doi: 10.1093/bioinformatics/btab540.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btab540</ArticleId><ArticleId IdType="pmc">PMC8665758</ArticleId><ArticleId IdType="pubmed">34302453</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Handsaker B., Wysoker A., Fennell T., Ruan J., Homer N., Marth G., Abecasis G., Durbin R. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078&#x2013;2079. doi: 10.1093/bioinformatics/btp352.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp352</ArticleId><ArticleId IdType="pmc">PMC2723002</ArticleId><ArticleId IdType="pubmed">19505943</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Toole A., Scher E., Underwood A., Jackson B., Hill V., McCrone J.T., Colquhoun R., Ruis C., Abu-Dahab K., Taylor B., et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol. 2021;7:veab064. doi: 10.1093/ve/veab064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J., Megill C., Bell S.M., Huddleston J., Potter B., Callender C., Sagulenko P., Bedford T., Neher R.A. Nextstrain: Real-time tracking of pathogen evolution. Bioinformatics. 2018;34:4121&#x2013;4123. doi: 10.1093/bioinformatics/bty407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bty407</ArticleId><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadriyan H., Dirja B.T., Suryani D., Yudhanto D. COVID-19 infection in the palatine tonsil tissue and detritus: The detection of the virus compartment withRT-PCR. BMJ Case Rep. 2021;14:e239108. doi: 10.1136/bcr-2020-239108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2020-239108</ArticleId><ArticleId IdType="pmc">PMC7871041</ArticleId><ArticleId IdType="pubmed">33547127</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann M., Allers K., Heldt C., Meinhardt J., Schmidt F., Rodriguez-Sillke Y. Human small intestinal infection by SARS-CoV-2 is characterized by a mucosal infiltration with activated CD8+T cells. Mucosal Immunol. 2021;14:1381&#x2013;1392. doi: 10.1038/s41385-021-00437-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00437-z</ArticleId><ArticleId IdType="pmc">PMC8379580</ArticleId><ArticleId IdType="pubmed">34420043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Yoon G.Y., Myoung J., Kim S., Ahn D. Robust and persistent SARS-CoV-2 infection in the human intestinal brush border expressing cells. Emerg. Microbes Infect. 2020;9:2169&#x2013;2179. doi: 10.1080/22221751.2020.1827985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1827985</ArticleId><ArticleId IdType="pmc">PMC7580600</ArticleId><ArticleId IdType="pubmed">32969768</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra M., Zahra A., Chauhan L.V., Thakkar R., Ng J., Joshi S., Spitzer E.D., Marcos L.A., Lipkin W.I., Mishra N. A Short Series of Case Reports of COVID-19 in Immunocompromised Patients. Viruses. 2022;14:934. doi: 10.3390/v14050934.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14050934</ArticleId><ArticleId IdType="pmc">PMC9145915</ArticleId><ArticleId IdType="pubmed">35632677</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Iwasaki A. Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines. Curr. HIV/AIDS Rep. 2022;19:5&#x2013;16. doi: 10.1007/s11904-021-00590-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11904-021-00590-x</ArticleId><ArticleId IdType="pmc">PMC8628277</ArticleId><ArticleId IdType="pubmed">34843064</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl S.H., Uzan-Yulzari A., Klainer H., Asiskovich L., Youngster M., Rinott E., Youngster I. SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women. JAMA. 2021;325:2013&#x2013;2014. doi: 10.1001/jama.2021.5782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5782</ArticleId><ArticleId IdType="pmc">PMC8042567</ArticleId><ArticleId IdType="pubmed">33843975</ArticleId></ArticleIdList></Reference><Reference><Citation>Atyeo C., Alter G. The multifaceted roles of breast milk antibodies. Cell. 2021;184:1486&#x2013;1499. doi: 10.1016/j.cell.2021.02.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.031</ArticleId><ArticleId IdType="pubmed">33740451</ArticleId></ArticleIdList></Reference><Reference><Citation>Henkle E., Steinhoff M.C., Omer S.B., Roy E., Arifeen S.E., Raqib R. The Effect of Exclusive Breast-feeding on Respiratory Illness in Young Infants in a Maternal Immunization Trial in Bangladesh. Pediatr. Infect. Dis. J. 2013;32:431&#x2013;435. doi: 10.1097/INF.0b013e318281e34f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0b013e318281e34f</ArticleId><ArticleId IdType="pubmed">23249922</ArticleId></ArticleIdList></Reference><Reference><Citation>Antunes K.H., Fachi J.L., de Paula R., da Silva E.F., Pral L.P., dos Santos A.A., Dias G.B.M., Vargas J.E., Puga R., Mayer E.Q., et al. Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response. Nat. Commun. 2019;10:3273. doi: 10.1038/s41467-019-11152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11152-6</ArticleId><ArticleId IdType="pmc">PMC6646332</ArticleId><ArticleId IdType="pubmed">31332169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos-Casals M., Brito-Zer&#xf3;n P., Mariette X. Systemic and organ-specific immune-related manifestations of COVID-19. Nat. Rev. Rheumatol. 2021;17:315&#x2013;332. doi: 10.1038/s41584-021-00608-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00608-z</ArticleId><ArticleId IdType="pmc">PMC8072739</ArticleId><ArticleId IdType="pubmed">33903743</ArticleId></ArticleIdList></Reference><Reference><Citation>Steensels D., Pierlet N., Penders J., Mesotten D., Heylen L. Comparison of SARS-CoV-2 Antibody Response Following Vaccination with BNT162b2 and mRNA-1273. JAMA. 2021;326:1533&#x2013;1535. doi: 10.1001/jama.2021.15125.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.15125</ArticleId><ArticleId IdType="pmc">PMC8406205</ArticleId><ArticleId IdType="pubmed">34459863</ArticleId></ArticleIdList></Reference><Reference><Citation>Barin B., Kasap U., Sel&#xe7;uk F., Volkan E., Ulu&#xe7;kan &#xd6;. Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: A prospective, longitudinal population-based study. Lancet Microbe. 2022;4:e274&#x2013;e283. doi: 10.1016/S2666-5247(21)00305-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(21)00305-0</ArticleId><ArticleId IdType="pmc">PMC8828370</ArticleId><ArticleId IdType="pubmed">35165669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong D., Xiao S., Debes A.K., Egbert E.R., Caturegli P., Colantuoni E., Milstone A.M. Durability of Antibody Levels After Vaccination With mRNA SARS-CoV-2 Vaccine in Individuals with or Without Prior Infection. JAMA. 2021;326:2524&#x2013;2526. doi: 10.1001/jama.2021.19996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.19996</ArticleId><ArticleId IdType="pmc">PMC8561429</ArticleId><ArticleId IdType="pubmed">34724529</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner J.S., O&#x2019;Halloran J.A., Kalaidina E., Kim W., Schmitz A.J., Zhou J.Q. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature. 2021;596:109&#x2013;113. doi: 10.1038/s41586-021-03738-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03738-2</ArticleId><ArticleId IdType="pmc">PMC8935394</ArticleId><ArticleId IdType="pubmed">34182569</ArticleId></ArticleIdList></Reference><Reference><Citation>Trofin F., Nastase E.V., Iancu L.S., Constantinescu D., Cianga C.M., Lunca C. Anti-RBD IgA and IgG Response and Transmission in Breast Milk of Anti-SARS-CoV-2 Vaccinated Mothers. Pathogens. 2022;11:286. doi: 10.3390/pathogens11030286.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11030286</ArticleId><ArticleId IdType="pmc">PMC8952534</ArticleId><ArticleId IdType="pubmed">35335610</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls A.C., Sprouse K.R., Bowen J.E., Joshi A., Franko N., Navarro M.J., Stewart C., Cameroni E., McCallum M., Goecker E.A., et al. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022;185:872&#x2013;880. doi: 10.1016/j.cell.2022.01.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.011</ArticleId><ArticleId IdType="pmc">PMC8769922</ArticleId><ArticleId IdType="pubmed">35123650</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Collier A.Y., Rowe M., Mardas F., Ventura J.D., Wan H. Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants. N. Engl. J. Med. 2022;386:1579&#x2013;1580. doi: 10.1056/NEJMc2201849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2201849</ArticleId><ArticleId IdType="pmc">PMC9006770</ArticleId><ArticleId IdType="pubmed">35294809</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B., Choudhary M.C., Regan J., Sparks J.A., Padera R.F., Qiu X., Solomon I.H., Kuo H.-H., Boucau J., Bowman K., et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host. N. Engl. J. Med. 2020;383:2291&#x2013;2293. doi: 10.1056/NEJMc2031364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Corey L., Beyrer C., Cohen M.S., Michael N.L., Bedford T., Rolland M. SARS-CoV-2 Variants in Patients with Immunosuppression. N. Engl. J. Med. 2021;385:562&#x2013;566. doi: 10.1056/NEJMsb2104756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2104756</ArticleId><ArticleId IdType="pmc">PMC8494465</ArticleId><ArticleId IdType="pubmed">34347959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp S.A., Collier D.A., Datir R.P., Ferreira I.A.T.M., Gayed S., Jahun A., Hosmillo M., Rees-Spear C., Mlcochova P., Lumb I.U., et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature. 2021;592:277&#x2013;282. doi: 10.1038/s41586-021-03291-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>